A Trial of Rehabilitation in Obesity Hypoventilation Syndrome (OHS)
Launched by GUY'S AND ST THOMAS' NHS FOUNDATION TRUST · Nov 30, 2011
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of OHS
- • Age \>18
- • BMI \> 30 kg/m2
- • Chronic hypercapnia , daytime PaCO2 \>6kPa
- • FEV1/FVC ≥70%
- • Evidence of sleep disordered breathing on overnight studies
- • Tolerated NIV \> 4hrs on 1st night during initiation of NIV
- Exclusion Criteria:
- • Hypercapnic respiratory failure secondary to an identifiable cause other than OHS.
- • Age \<18
- • Respiratory acidosis (pH \<7.35)
- • Wheelchair/bedbound patients
- • Cognitive impairment which would prevent the subject from complying with trial protocol
- • Unstable coronary artery syndrome
- • Patients postintubation or decannulation following treatment requiring acute hypercapnic respiratory failure
- • Patients undergoing renal replacement therapy
- • Critical peripheral vascular disease
- • Disabling locomotor disability preventing participation in exercises involved in the rehabilitation programme
- • Pregnancy
- • Bariatric surgery planned within 3 months
About Guy's And St Thomas' Nhs Foundation Trust
Guy's and St Thomas' NHS Foundation Trust is a leading healthcare organization in the United Kingdom, renowned for its commitment to delivering high-quality patient care, innovative research, and clinical excellence. As a prominent academic health science center, the Trust integrates cutting-edge research with clinical practice, facilitating the translation of scientific discoveries into improved treatment options. With a diverse portfolio of clinical trials across various medical specialties, Guy's and St Thomas' NHS Foundation Trust plays a pivotal role in advancing healthcare knowledge and enhancing patient outcomes, while maintaining the highest ethical standards in research and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Nicholas Hart
Study Director
Guy's and St Thomas' NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials